2017
DOI: 10.1002/cbin.10775
|View full text |Cite
|
Sign up to set email alerts
|

Formation of the IGF1R/CAV1/SRC tri‐complex antagonizes TRAIL‐induced apoptosis in gastric cancer cells

Abstract: Lipid rafts provide a biological platform for apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). We previously reported that insulin-like growth factor 1 receptor (IGF1R) translocation into lipid rafts helped to explain TRAIL resistance. However, it was not clear whether TRAIL resistance was caused by the interaction of IGF1R with caveolin-1 (CAV1) and the non-receptor tyrosine kinase SRC in lipid rafts of gastric cancer cells. Here, we observed high IGF1R expression in TRAIL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 29 publications
0
8
0
Order By: Relevance
“…The inhibition of IR/IGF1R reduced the epithelial-mesenchymal transition and cancer stem cell-like traits in 'resistant cells' of cholangiocarcinoma [32]. The elevated expression of IGF1R was observed in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant gastric cancer cells, thus enhancing TRAIL resistance in gastric cancer cells [33]. According to genes encoding proteins related to insulin receptors, IGF1R is able to stimulate renal cancer cells [34].…”
Section: Discussionmentioning
confidence: 99%
“…The inhibition of IR/IGF1R reduced the epithelial-mesenchymal transition and cancer stem cell-like traits in 'resistant cells' of cholangiocarcinoma [32]. The elevated expression of IGF1R was observed in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant gastric cancer cells, thus enhancing TRAIL resistance in gastric cancer cells [33]. According to genes encoding proteins related to insulin receptors, IGF1R is able to stimulate renal cancer cells [34].…”
Section: Discussionmentioning
confidence: 99%
“…BGC823 and SGC7901 cells were exposed to 10, 20, and 50 μg/mL β‐elemene for 24 h. β‐elemene inhibited cell proliferation in dose‐dependent manner (Figure A). To detect if β‐elemene enhanced the sensitivity of gastric cancer cells to TRAIL, the two cells were simultaneously treated with β‐elemene (20 μg/mL) and/or TRAIL (100 ng/mL) as per our previous study (Guo et al, ). β‐elemene combined with TRAIL obviously inhibited cell viability compared to β‐elemene or TRAIL alone ( P < 0.05, Figure B).…”
Section: Resultsmentioning
confidence: 99%
“…The inhibition of IR/IGF1R reduced epithelial-mesenchymal transition and cancer stem cell-like traits in resistant cells of cholangiocarcinoma [26]. The elevated expression of IGF1R was observed in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant gastric cancer cells, enhancing TRAIL resistance in gastric cancer cells [27]. As genes encoding proteins related to insulin receptor, IGF1R could stimulate renal cancer cells [28].…”
Section: Discussionmentioning
confidence: 99%